financetom
Business
financetom
/
Business
/
--Eli Lilly Wins FDA Approval for Alzheimer's Drug Kisunla
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Eli Lilly Wins FDA Approval for Alzheimer's Drug Kisunla
Jul 2, 2024 11:06 AM

01:40 PM EDT, 07/02/2024 (MT Newswires) --

Price: 902.50, Change: -11.87, Percent Change: -1.30

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Court rejects challenge to 'quick-pay' for lawyers in $600 mln train derailment settlement
Court rejects challenge to 'quick-pay' for lawyers in $600 mln train derailment settlement
Nov 25, 2025
Nov 25 (Reuters) - A U.S appeals court on Tuesday largely upheld a lower court's handling of attorney fees in the $600 million settlement over Norfolk Southern's ( NSC ) freight train derailment in East Palestine, Ohio, rejecting most of a challenge by law firm Morgan & Morgan but reviving its claim that it was shortchanged. The 6th U.S. Circuit...
Radian Strikes $373 Million Excess-of-Loss Reinsurance Deal
Radian Strikes $373 Million Excess-of-Loss Reinsurance Deal
Nov 25, 2025
06:02 PM EST, 11/25/2025 (MT Newswires) -- Radian Group ( RDN ) said late Tuesday its Radian Guaranty unit has agreed to principal terms on an excess of loss reinsurance arrangement with a panel of third-party reinsurance providers. The deal secures about $373 million of excess of loss coverage on certain policies written from 2016 through 2021, Radian said. It...
Critical Metals Says Court Decision Won't Affect Mining Start at Wolfsberg
Critical Metals Says Court Decision Won't Affect Mining Start at Wolfsberg
Nov 25, 2025
06:02 PM EST, 11/25/2025 (MT Newswires) -- Critical Metals (CRML) said late Tuesday that its subsidiary ECM Lithium AT GmbH has received a decision from Austria's Federal Administrative Court regarding the environmental review requirements for its Koralpe lithium project. The court overturned an earlier ruling by the Carinthian state government that had determined the project did not require an environmental...
Myriad Genetics Collaborates With Clairity, MagView to Roll Out AI Platform for Breast Cancer Risk Assessment
Myriad Genetics Collaborates With Clairity, MagView to Roll Out AI Platform for Breast Cancer Risk Assessment
Nov 25, 2025
06:03 PM EST, 11/25/2025 (MT Newswires) -- Myriad Genetics ( MYGN ) entered a partnership with Clairity and MagView to roll out an integrated artificial intelligence platform for breast cancer risk assessment across the US, the companies said late Tuesday. Patients will benefit from an integrated view of genotype through Myriad's MyRisk hereditary cancer test and phenotype using Clairity Breast...
Copyright 2023-2026 - www.financetom.com All Rights Reserved